Key | % Net Assets |
---|---|
UBS | 4.5% |
Novartis | 4.4% |
BNP Paribas | 4.4% |
DnB NOR Bank | 4.0% |
Other | 82.7% |
Name | % Net Assets |
---|---|
UBS | 4.5% |
Novartis | 4.4% |
BNP Paribas | 4.4% |
DnB NOR Bank | 4.0% |
Roche Holding | 3.8% |
Brenntag | 3.5% |
Hexagon | 3.5% |
Assa Abloy | 3.4% |
Svenska Cellulosa | 3.3% |
Henkel | 3.3% |
Key | % Net Assets |
---|---|
Industrials | 20.00% |
Consumer Goods | 18.60% |
Health Care | 17.50% |
Financials | 16.80% |
Basic Materials | 16.50% |
Date | 14-May-2024 |
---|---|
NAV | 193.30p |
Currency | GBP |
Change | -0.20p |
% | -0.10% |
YTD change | -0.50p |
YTD % | -0.26% |
Fund Inception | 03/10/2003 |
---|---|
Fund Manager | Leon Howard-Spink |
TER | 1.68 (15-Mar-2012) |
Minimum Investment | |
---|---|
Initial | £1000 |
Additional | n/a |
Savings | £50 |
Charges | |
---|---|
Initial | n/a |
Annual Mang't | 1.50% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.02 |
Sharpe ratio | 0.15 |
You are here: research